Alan Lafley - Procter Gamble Executive Chairman and Member of Proxy Committee

PG
 Stock
  

USD 146.11  2.32  1.61%   

  Chairman
Mr. Alan G. Lafley is no longer Executive Chairman of the Board of the Company. effective June 30 2016. He was Chairman of the Board President Chief Executive Officer of The Procter Gamble Company. Mr. Lafley originally joined the Company in 1977 and held positions of increasing responsibility in the U.S. and internationally until he was elected President and Chief Executive Officer in 2000 a position he held until June 30 2009. On July 1 2002 Mr. Lafley was elected Chairman of the Board a position he held until January 2010. During the past five years in addition to his roles as a Company employee Mr. Lafley served as a consultant to the Company and as a member of the boards of directors of public companies Dell Inc. and General Electric Company. He no longer serves on these boards. Since his retirement from the Company he served as a Senior Advisor at Clayton Dubilier Rice LLC a private equity partnership and was appointed by President Obama to serve on The Presidents Council on Jobs and Competitiveness. Mr. Lafley consulted with a number of Fortune 50 companies on business and innovation strategy. He also advised on CEO succession and executive leadership development and coached experienced new and potential CEOs. He currently serves on the board of directors of Legendary Pictures LLC .
Age: 67        
513 983-1100  www.pg.com

Procter Gamble Management Efficiency

Procter Gamble has Return on Asset (ROA) of 9.85 % which means that for every $100 of asset, it generated profit of $9.85. This is typical in the industry. Likewise, it shows return on total equity (ROE) of 31.6 %, which means that it produced $31.6 on every 100 dollars invested by current stockholders. Procter Gamble management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities. The current year Return on Sales is expected to grow to 0.13, whereas Return on Investment is forecasted to decline to 17.17. Procter Gamble Current Assets are projected to decrease significantly based on the last few years of reporting. The past year's Current Assets were at 20.78 Billion. The current year Assets Non Current is expected to grow to about 88 B, whereas Net Current Assets as percentage of Total Assets are forecasted to decline to (9.93) .
The company reports 33.67 B of total liabilities with total debt to equity ratio (D/E) of 0.74, which is normal for its line of buisiness. Procter Gamble has a current ratio of 0.67, implying that it has not enough working capital to pay out debt commitments in time. Debt can assist Procter Gamble until it has trouble settling it off, either with new capital or with free cash flow. So, Procter Gamble's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Procter Gamble sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Procter to invest in growth at high rates of return. When we think about Procter Gamble's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing few of many executives

CHAIRMAN Since

Michael HoffmanToro Company
N/A
Richard OlsonToro Company
2017
Lucio NotoPhilip Morris International
2021
Susan ArnoldWalt Disney
2021
Vincent ByrdJM Smucker
N/A
Robert IgerWalt Disney
2020
Richard SandsConstellation Brands
2019
Douglas McMillonWalmart
2014
Robert SandsConstellation Brands
2019
Timothy SmuckerJM Smucker
2016
Louis CamilleriPhilip Morris International
2014
Bob IgerWalt Disney
2012
Michael DukeWalmart
N/A
Kevin McNamaraTyson Foods
2020
Greg PennerWalmart
2015
Douglas SandersSprouts Farmers Market
2015
Philip KnightNike Inc
2004
The Procter Gamble Company provides branded consumer packaged goods to consumers in North and Latin America, Europe, the Asia Pacific, Greater China, India, the Middle East, and Africa. The Procter Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio. Procter Gamble operates under Household Personal Products classification in the United States and is traded on New York Stock Exchange. It employs 101000 people. Procter Gamble (PG) is traded on New York Stock Exchange in USA and employs 101,000 people.

Procter Gamble Leadership Team

Elected by the shareholders, the Procter Gamble's board of directors comprises two types of representatives: Procter Gamble inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Procter. The board's role is to monitor Procter Gamble's management team and ensure that shareholders' interests are well served. Procter Gamble's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Procter Gamble's outside directors are responsible for providing unbiased perspectives on the board's policies.
Kathleen Fish, Chief Research, Development and Innovation Officer
Craig Buchholz, Chief Communications Officer and Vice President – Communications, Personal Health Care and Oral Care
Mary FergusonMcHugh, Group President - Global Family Care and Global Brand Creation and Innovation, P&G Ventures
Kenneth Chenault, Independent Director
Debra Lee, Independent Director
Mindy Sherwood, President Global Walmart
Amy Chang, Independent Director
Nelson Peltz, Independent Director
Martin Riant, Group Pres and Advisor to the CEO
Hatsunori Kiriyama, President - Asia
Magesvaran Suranjan, President - Asia Pacific Selling and Market Operations
Kirti Singh, Chief Analytics and Insights Officer
Tarek Farahat, President - Latin America
Francis Blake, Independent Director
Thomas Finn, President - Personal Health Care
Mohamed Samir, President - India, Middle East and Africa (IMEA) Selling and Market Operations
Alexandra Keith, President - Global Hair Care and Beauty Sector
Susan DesmondHellmann, Independent Director
Valarie Sheppard, Controller and Treasurer and Executive Vice President - Company Transition Leader
Fama Francisco, Chief Executive Officer - Baby and Feminine Care
Loic Tassel, President - Europe
Margaret Whitman, Independent Director
Walter McNerney, Lead Independent Director
Terry Lundgren, Independent Director
Shelly McNamara, Senior Vice President of Human Resources
Angela Braly, Independent Director
Giovanni Ciserani, Group President of Global Fabric and Home Care and Global Baby and Feminine Care
M Grabowski, Chief Human Resource Officer
Victor Aguilar, Chief Research, Development and Innovation Officer
Javier Polit, Chief Information Officer
B Allen, Independent Director
James McNerney, Lead Independent Director
Ernesto Zedillo, Independent Director
Steven Bishop, Group President - Global Feminine and Family Care
Scott Cook, Independent Director
Henry Karamanoukian, President Go-to-Market, China and Hair Care, Greater China
Sundar Raman, President - Fabric Care, North America and P&G Professional, Global
Ernesto Leon, Independent Director
R Keith, President - Global Hair Care and Beauty Sector
Ma Francisco, Chief Executive Officer - Baby and Feminine Care
Yannis Skoufalos, Global Product Supply Officer
Linda ClementHolmes, CIO
Jennifer Davis, President - Feminine Care
John Chevalier, Director - Investor Relations
Juan Posada, President - Latin America Selling and Market Operations
Alan Lafley, Executive Chairman and Member of Proxy Committee
Jeffrey Schomburger, Global Sales Officer
Monica Turner, Senior Vice President - Sales, North America
Vittorio Cretella, Chief Information Officer
Christine McCarthy, Independent Director
Patricia Woertz, Independent Director
Shailesh Jejurikar, Chief Operating Officer, Chief Executive Officer - Fabric and Home Care
Philip Duncan, Chief Design Officer
Andre Schulten, Chief Financial Officer
Marc Pritchard, Global Brand Building Officer
Markus Strobel, President - Skin & Personal Care
David Taylor, Chairman of the Board, President, Chief Executive Officer
Mark Biegger, Global Human Resources Officer
Joseph Jimenez, Lead Independent Director
Matthew Price, President - Greater China Selling and Market Operations
Julio Nemeth, President - Global Business Services
Laura Becker, President - Global Business Services
Deborah Majoras, Chief Legal Officer, Secretary
Jon Moeller, Vice Chairman of the Board, President, Chief Executive Officer
Patrice Louvet, Group President - Global Beauty
Charles Pierce, Group President - Global Grooming
Gary Coombe, President - Europe Selling and Market Operations
Carolyn Tastad, Group President - North America Selling and Market Operations

Procter Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Procter Gamble a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Procter Gamble without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Performance Analysis Now

   

Performance Analysis

Check effects of mean-variance optimization against your current asset allocation
All  Next Launch Module

Currently Active Assets on Macroaxis

Please check Your Equity Center. Note that the Procter Gamble information on this page should be used as a complementary analysis to other Procter Gamble's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Complementary Tools for Procter Stock analysis

When running Procter Gamble price analysis, check to measure Procter Gamble's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procter Gamble is operating at the current time. Most of Procter Gamble's value examination focuses on studying past and present price action to predict the probability of Procter Gamble's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Procter Gamble's price. Additionally, you may evaluate how the addition of Procter Gamble to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Is Procter Gamble's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Procter Gamble. If investors know Procter will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Procter Gamble listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.051
Market Capitalization
345 B
Quarterly Revenue Growth YOY
0.07
Return On Assets
0.0985
Return On Equity
0.32
The market value of Procter Gamble is measured differently than its book value, which is the value of Procter that is recorded on the company's balance sheet. Investors also form their own opinion of Procter Gamble's value that differs from its market value or its book value, called intrinsic value, which is Procter Gamble's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Procter Gamble's market value can be influenced by many factors that don't directly affect Procter Gamble's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Procter Gamble's value and its price as these two are different measures arrived at by different means. Investors typically determine Procter Gamble value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Procter Gamble's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.